3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is ever more attracting clinical attention due to sparse data suggesting unique pharmacological actions. Preliminary analyses suggest that 3-HPC may exhibit distinct responses on the central system, potentially influencing to some of the unexplained manifestations related with PCP